Facts
The Canadian Centre for Ethics in Sport (CCES) alleges Ashly Kraayeveld (the athlete) for a violation of the Canadian Anti-Drugs Program. On June 28, 2012 she competed in the Canadian Senior Taekwondo Championships in Toronto. She won her division and was sent to doping control shortly after the event. The urine sample that she provided resulted in an adverse analytical finding for Furosemide. Furosemide is a prohibited specified substance in the 2012 World Anti Doping Agency (“WADA”) Prohibited List.
History
The athlete admitted that she took Furosemide and in so doing
committed an anti-doping rule violation. She stated that she ingested Furosemide on June 27, 2012, the evening before competing in the Senior Nationals when she took a pill given to her by her mother to relieve the pain and discomfort that she was experiencing due to the onset of her menstrual cycle. She had no intention of enhancing her performance. She further submits that her adverse analytical finding resulted from her lack of sophistication as an athlete, her lack of doping control experience and education and an error in judgment.
Decision
Arbitrator Fraser imposed a sanction of four months ineligibility from sport, as a result of Ms. Kraayeveld’s prompt admission and early acceptance of a provisional suspension, the period of ineligibility began on June 28, 2012, the date of sample collection, and concluded on October 28, 2012.
